MARKET

HALO

HALO

Halozyme Thrp
NASDAQ
62.95
-1.71
-2.64%
After Hours: 62.88 -0.07 -0.11% 19:49 12/04 EST
OPEN
62.87
PREV CLOSE
64.66
HIGH
66.00
LOW
61.70
VOLUME
4.21M
TURNOVER
--
52 WEEK HIGH
79.50
52 WEEK LOW
46.26
MARKET CAP
7.40B
P/E (TTM)
13.24
1D
5D
1M
3M
1Y
5Y
1D
Correction to Halozyme Granted Injunction Against Merck & Co. Article
Dow Jones · 16h ago
Halozyme granted injunction in Germany barring Merck's subcutaneous Keytruda
Seeking Alpha · 17h ago
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case
Dow Jones · 17h ago
*Halozyme: German Proceedings Part of Global Enforcement of MDASE Patents Against Infringement by Keytruda SC
Dow Jones · 18h ago
*Halozyme: Injunction Orders Merck & Co. to Refrain From Distributing, Offering Keytruda SC in Germany
Dow Jones · 18h ago
*Halozyme Therapeutics: German Court Grants Preliminary Injunction Against Merck & Co.
Dow Jones · 18h ago
Halozyme Therapeutics Granted Preliminary Injunction From German Court Against Merck's Keytruda
Benzinga · 18h ago
Halozyme Therapeutics Secures Preliminary Injunction Against Merck’s Keytruda SC in Germany Over Patent Infringement
Reuters · 18h ago
More
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.

Webull offers Halozyme Therapeutics, Inc. stock information, including NASDAQ: HALO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HALO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HALO stock methods without spending real money on the virtual paper trading platform.